IbrutinibClostridium difficile infection: case report

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2018年 / 1726卷 / 1期

关键词：

D O I：

10.1007/s40278-018-53831-x

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：192 / 192

相关论文

共 50 条

[41] Clindamycin/gentamicinClostridioides difficile infection: case report
Reactions Weekly, 2021, 1881 (1) : 79 - 79
[42] Ciprofloxacin/cotrimoxazoleClostridioides difficile infection: case report
Reactions Weekly, 2020, 1809 (1) : 86 - 86
[43] Ampicillin/gentamicinClostridium difficile infection: case report
Reactions Weekly, 2019, 1766 (1) : 29 - 29
[44] VedolizumabRecurrent Clostridium difficile infection: case report
Reactions Weekly, 2019, 1749 (1) : 388 - 388
[45] Ustekinumab/VedolizumabClostridium difficile infection: case report
Reactions Weekly, 2025, 2043 (1) : 374 - 374
[46] Multiple drugsClostridium difficile infection: case report
Reactions Weekly, 2016, 1592 (1) : 158 - 158
[47] Esomeprazole/omeprazoleClostridium difficile infection: case report
Reactions Weekly, 2015, 1578 (1) : 137 - 137
[48] VinorelbineFatal Clostridium difficile infection: case report
Reactions Weekly, 2010, 1323 (1) : 37 - 37
[49] BasiliximabAtypical Clostridium difficile infection: case report
Reactions Weekly, 2017, 1652 (1) : 61 - 61
[50] Isoniazid/rifampicinClostridium difficile infection: case report
Reactions Weekly, 2018, 1716 (1) : 174 - 174

← 1 2 3 4 5 →